Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021

Abstract Background Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are the currently recommended first- and second-line therapies for uncomplicated Plasmodium falciparum infections in Togo. This study assessed the efficacy of these combinations, the proportion of Day3-positive...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Ameyo Monique Dorkenoo, Marian Warsame, Essoham Ataba, Manani Hemou, Kossi Yakpa, Efoe Sossou, M’badi Mitigmsagou, Carmel Diwaba Teou, Emmanuelle Caspar, Laurence Ma, Koffi Edem Djadou, Tinah Atcha-Oubou, Charlotte Rasmussen, Didier Menard
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2024-04-01
Seri Bilgileri:	Malaria Journal
Konular:	Artemether-lumefantrine Dihydroartemisinin-piperaquine Plasmodium falciparum Efficacy Molecular markers of antimalarial drug resistance Togo
Online Erişim:	https://doi.org/10.1186/s12936-024-04922-1
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!